equimolar concentrations were analyzed by LC/MS-SIM. In
this comparison, the peak area of the piperidine amide was
significantly larger than the peak area of the N-acyl sulfon-
amide SZ4TA2, which clearly indicates that the electrospray
ionization of the piperidine amide is better than that of
SZ4TA2. Thus, it can be concluded that though the piperidine
amide can be identified by LC/MS-SIM, it has been formed in
the incubation sample only to minor amounts in comparison
to the N-acyl sulfonamide SZ4TA2. These results suggest that
the unwanted byproduct piperidine amide did not have an
unfavorable impact on the kinetic TGS incubations and the hit
compound SZ4TA2 is easily detectable by LC/MS-SIM
analysis.
Scheme 5 Kinetic TGS incubations with TA2 generated from TA20.
from the corresponding thioesters TA10–TA30 were incubated
as binary mixtures at 20 mM concentration each in the
presence and absence of Bcl-XL in the appropriate phosphate
buffer at 37 1C for 6 hours. At the same time as a control
experiment, all binary building block combinations with
sulfonylazides SZ1–SZ6 and the thioacids TA1–TA3, which
were synthesized and purified as thioacids, were incubated
with and without Bcl-XL. Contrary to the previous results,4
the amplification factor for hit combination SZ4TA2, the ratio
between SZ4TA2 in the Bcl-XL-templated reaction and
SZ4TA2 in the non-templated reaction, was not detected in
the incubation samples containing the fragments SZ4 and
TA2, which derived from the thioester TA20. The strong
basicity of DBU was considered to change the pH of the
Bcl-XL-containing incubation sample and thereby possibly
affect the protein conformation or even denaturing it.
In conclusion, we have developed a practical, one-pot
variant of the sulfo-click reaction, in which Fm thioesters
are rapidly deprotected and further reacted with sulfonylazides
to give N-acyl sulfonamides in high yields. This variant of the
sulfo-click reaction has also been shown to be applicable for
kinetic TGS screening. We are currently using this kinetic TGS
approach for the screening of various protein–protein inter-
action targets.
We thank Dr. Hong-Gang Wang for the help and guidance
to express and purify Bcl-XL and Sameer Kulkarni for fruitful
discussions. We are also grateful to the James and Esther King
Biomedical Research Program (NIR grant 07KN-08) for
financial support.
Therefore, the kinetic TGS experiments were repeated with
a weaker base (Scheme 5). Piperidine was considered to be a
good candidate, even though it has been proven to undergo a
side reaction yielding piperidine amides. After the deprotection
of the Fm thioesters, it was assumed that the dilution and the
buffering effect by the phosphate buffer of the incubation
samples may significantly decrease the nucleophilicity of
piperidine and thus suppress the formation of unwanted
piperidine amides. The thioacids TA1–TA3 were rapidly
generated by the treatment of thioesters TA10–TA30 with a
mixture of 5% piperidine/DMF and immediately diluted with
methanol to 2 mM stock solutions. Kinetic TGS incubation
samples were prepared with and without Bcl-XL in all possible
fragment combinations and then analyzed by LC/MS-SIM.
Gratifyingly, an amplification factor for hit combination
SZ4TA2 in the incubation samples containing the thioacid
TA2 derived from the thioester TA20 (see Fig. S1, traces C and
D in ESIz) was calculated to be in the same range as the
amplification for the Bcl-XL-templated incubations containing
the purified thioacid TA2 (see Fig. S1, traces A and B in ESIz).
Next, studies were conducted to check whether the
unwanted piperidine amide was formed during the kinetic
TGS incubations with thioacid TA2 derived from thioester
TA20. LC/MS-SIM analysis set to simultaneously detect ions
with masses corresponding to SZ4TA2 and piperidine amide
identified the formation of both N-acyl sulfonamide SZ4TA2
and piperidine amide in both the non-templated reaction and
the Bcl-XL-templated reactions (Fig. S2 in ESIz). As expected,
the amount of SZ4TA2 was increased in the Bcl-XL-containing
incubation sample, while the piperidine amide was detected at
approximately the same amounts in the Bcl-XL-templated and
non-templated incubations. Further attempts were made to
estimate the amounts of SZ4TA2 and piperidine amide
formed during the kinetic TGS. Both compounds were synthesized
and mixtures containing SZ4TA2 and piperidine amide at
Notes and references
1 (a) H. C. Kolb, M. G. Finn and K. B. Sharpless, Angew. Chem.,
Int. Ed., 2001, 40, 2004–2021; (b) J. E. Moses and
A. D. Moorhouse, Chem. Soc. Rev., 2007, 36, 1249–1262;
(c) C. O. Kappe and E. Van der Eycken, Chem. Soc. Rev., 2010,
39, 1280–1290.
2 C. E. Hoyle, A. B. Lowe and C. N. Bowman, Chem. Soc. Rev.,
2010, 39, 1355–1387.
3 (a) N. Shangguan, S. Katukojvala, R. Greenberg and
L. J. Williams, J. Am. Chem. Soc., 2003, 125, 7754–7755;
(b) R. V. Kolakowski, N. Shangguan, R. R. Sauers and
L. J. Williams, J. Am. Chem. Soc., 2006, 128, 5695–5702; (c) D.
T. S. Rijkers, R. Merkx, C.-B. Yim, A. J. Brouwer and R. M.
J. Liskamp, J. Pept. Sci., 2010, 16, 1–5.
4 (a) X. Hu, J. Sun, H.-G. Wang and R. Manetsch, J. Am. Chem.
Soc., 2008, 130, 13820–13821; (b) S. S. Kulkarni, X. Hu, K. Doi,
H. G. Wang and R. Manetsch, ACS Chem. Biol., 2011, 6, 724–732;
(c) X. D. Hu and R. Manetsch, Chem. Soc. Rev., 2010, 39,
1316–1324.
5 (a) K. B. Sharpless and R. Manetsch, Expert Opin. Drug Discovery,
2006, 1, 525–538; (b) S. K. Mamidyala and M. G. Finn, Chem. Soc.
Rev., 2010, 39, 1252–1261.
6 (a) A. P. Combs, et al., J. Med. Chem., 2005, 48, 6544–6548;
(b) T. Oltersdorf, et al., Nature, 2005, 435, 677–681;
(c) M. D. Wendt, et al., J. Med. Chem., 2006, 49, 1165–1181.
7 (a) I. Bae, H. Han and S. Chang, J. Am. Chem. Soc., 2005, 127,
2038–239; (b) S. H. Cho, E. J. Yoo, I. Bae and S. Chang, J. Am.
Chem. Soc., 2005, 127, 16046–16047; (c) M. P. Cassidy, J. Raushel
and V. V. Fokin, Angew. Chem., Int. Ed., 2006, 45, 3154–3157.
8 X. Wu and L. Hu, J. Org. Chem., 2007, 72, 765–774.
9 Y. Rao, X. Li, P. Nagorny, J. Hayashida and S. J. Danishefsky,
Tetrahedron Lett., 2009, 50, 6684–6686.
10 S. Vetter, Synth. Commun., 1998, 28, 3219–3223.
11 D. Crich, K. Sana and S. Guo, Org. Lett., 2007, 9, 4423–4426.
12 D. Crich and K. Sasaki, Org. Lett., 2009, 11, 3514–3517.
13 S. Hindley, S. A. Ward, R. C. Storr, N. L. Searle, P. G. Bray,
B. K. Park, J. Davies and P. M. O’Neill, J. Med. Chem., 2002, 45,
1052–1063.
c
1528 Chem. Commun., 2012, 48, 1526–1528
This journal is The Royal Society of Chemistry 2012